Genesis Energy (ASX:GNE) Explores Continuation of Huntly Power Operations
Genesis Energy (ASX:GNE) and partners are exploring the extension of Huntly Power Station operations to enhance national energy security.
Tag: Corporate Strategy & Guidance
Generation Development Group Limited (ASX:GDG) Completes $233.3m Institutional Equity Raise
Generation Development Group Limited (ASX:GDG) successfully completes a $233.3m institutional equity raising to fund the acquisition of Evidentia Group Holdings.
Bravura Solutions Limited (ASX:BVS) Announces 1H25 Results, Dividend and Guidance Update
Bravura Solutions Limited (ASX:BVS) reports increased 1H25 revenue and EBITDA, announces dividends, and upgrades FY25 guidance.
Critica Limited (ASX: CRI) Unveils Maiden Mineral Resource for Jupiter Project
Critica Limited (ASX: CRI) announces its maiden Mineral Resource Estimate for the Jupiter Project, establishing Australia’s largest high-grade rare earth resource.
Elixir Energy (ASX:EXR) Expands Taroom Trough Project with Farmout Agreements and Equity Raise
Elixir Energy (ASX:EXR) expands its Taroom Trough Project with farmout agreements, increased resources, and a $9 million equity raise.
Elixir Energy Limited (ASX:EXR) Reinstated to Quotation
Elixir Energy Limited (ASX:EXR) has been reinstated to quotation following its Taroom Trough expansion and fund raise announcement.
Belararox Limited (ASX:BRX) Commences Malambo and Tambo Drilling
Belararox Limited (ASX:BRX) begins drilling at Malambo and Tambo South, observing key copper sulphides in initial core samples.
Arizona Lithium Limited (ASX:AZL) Deploys KTS Li-Pro DLE Unit at Prairie Project
Arizona Lithium (ASX:AZL) deploys Koch Technology Solutions’ largest DLE unit at Prairie Project, enhancing lithium production capabilities.
Ardea Resources (ASX:ARL) Awards $5.4M Contract for Kalgoorlie Project
Ardea Resources (ASX:ARL) advances its Kalgoorlie Nickel Project by awarding a $5.4M contract to Lycopodium for the hydrogen sulphide plant.
Clarity Pharmaceuticals (ASX:CU6) Enhances Breast Cancer Pipeline with Cu-SAR-trastuzumab
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.